These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Scleroderma-like Impairment in the Network of Telocytes/CD34 Rosa I; Romano E; Fioretto BS; Guasti D; Ibba-Manneschi L; Matucci-Cerinic M; Manetti M Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830288 [TBL] [Abstract][Full Text] [Related]
3. A convenient method for producing the bleomycin-induced mouse model of scleroderma by weekly injections using a methylcellulose gel. Jun JB; Kim JK; Na YI; Jang SM; Paik SS; Kim YH Rheumatol Int; 2012 May; 32(5):1443-7. PubMed ID: 21448642 [TBL] [Abstract][Full Text] [Related]
5. Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma. Park GT; Yoon JW; Yoo SB; Song YC; Song P; Kim HK; Han J; Bae SJ; Ha KT; Mishchenko NP; Fedoreyev SA; Stonik VA; Kim MB; Kim JH Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922418 [TBL] [Abstract][Full Text] [Related]
6. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404 [TBL] [Abstract][Full Text] [Related]
7. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
9. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma. Yamamoto T; Nishioka K Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070 [TBL] [Abstract][Full Text] [Related]
10. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Castelino FV; Seiders J; Bain G; Brooks SF; King CD; Swaney JS; Lorrain DS; Chun J; Luster AD; Tager AM Arthritis Rheum; 2011 May; 63(5):1405-15. PubMed ID: 21305523 [TBL] [Abstract][Full Text] [Related]
11. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613 [TBL] [Abstract][Full Text] [Related]
12. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis. Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K Front Immunol; 2019; 10():1861. PubMed ID: 31481954 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling. Park JS; Kim C; Choi J; Jeong HY; Moon YM; Kang H; Lee EK; Cho ML; Park SH J Transl Med; 2024 Apr; 22(1):323. PubMed ID: 38561750 [TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176 [TBL] [Abstract][Full Text] [Related]
18. Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis. Ruzehaji N; Avouac J; Elhai M; Frechet M; Frantz C; Ruiz B; Distler JH; Allanore Y Arthritis Res Ther; 2015 May; 17(1):145. PubMed ID: 26025306 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of kaempferol on skin fibrosis in systemic sclerosis by the suppression of oxidative stress. Sekiguchi A; Motegi SI; Fujiwara C; Yamazaki S; Inoue Y; Uchiyama A; Akai R; Iwawaki T; Ishikawa O J Dermatol Sci; 2019 Oct; 96(1):8-17. PubMed ID: 31447184 [TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation. Zhu L; Song Y; Li M J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]